Nebivolol NDC 70756-025

NDC codes

FDA NDC Directory

Product NDC (as listed)70756-025Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70756-0025Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70756-025-30	70756002530	30 TABLET in 1 BOTTLE (70756-025-30)Marketed from Nov 14, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nebivolol
Generic name (nonproprietary): nebivolol
Active ingredients: Nebivolol hydrochloride — 2.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Lifestar Pharma LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216172
Marketing start: Nov 14, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 70756-025_2ffb359c-7e4b-44ef-a0c7-451ac966f6b6SPL ID 2ffb359c-7e4b-44ef-a0c7-451ac966f6b6SPL set ID 2639abce-a5ca-4b7f-99d7-026ab3233aaaRxCUI 387013, 751612, 751618, 827073UNII JGS34J7L9IUPC 0370756291305, 0370756291909, 0370756025306, 0370756292906, 0370756293903
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470756002530 followed by a unit qualifier and the quantity

Package 70756-0025-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 13, 2023.

Indications (excerpt from the label)

Nebivolol tablets are a beta-adrenergic blocking agent indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) 1.1 Hypertension Nebivolol tablets are indicated for the treatment of hypertension, to lower blood pressure [see Clinical Studies (14.1) ]. Nebivolol tablets may be used alone or in combination with other antihypertensive agents [see Drug Interactions (7) ]. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216172

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216172
Product	Strength	Form · route	Labeler	Product NDC
Nebivolol	Nebivolol hydrochloride 10 mg/1	TabletOral	Lifestar Pharma LLC	70756-292
Nebivolol	Nebivolol hydrochloride 5 mg/1	TabletOral	Lifestar Pharma LLC	70756-291
Nebivolol	Nebivolol hydrochloride 20 mg/1	TabletOral	Lifestar Pharma LLC	70756-293